Details for New Drug Application (NDA): 214361
✉ Email this page to a colleague
The generic ingredient in VERAPAMIL HYDROCHLORIDE is verapamil hydrochloride. There are seventeen drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the verapamil hydrochloride profile page.
Summary for 214361
Tradename: | VERAPAMIL HYDROCHLORIDE |
Applicant: | Gland Pharma Ltd |
Ingredient: | verapamil hydrochloride |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 214361
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
VERAPAMIL HYDROCHLORIDE | verapamil hydrochloride | INJECTABLE;INJECTION | 214361 | ANDA | Sagent Pharmaceuticals | 25021-312 | 25021-312-02 | 25 VIAL in 1 CARTON (25021-312-02) / 2 mL in 1 VIAL |
VERAPAMIL HYDROCHLORIDE | verapamil hydrochloride | INJECTABLE;INJECTION | 214361 | ANDA | Sagent Pharmaceuticals | 25021-312 | 25021-312-04 | 5 VIAL in 1 CARTON (25021-312-04) / 4 mL in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 2.5MG/ML | ||||
Approval Date: | Oct 15, 2020 | TE: | AP | RLD: | No |
Complete Access Available with Subscription